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A. lntroduction 
Currently in cancer research much em-
phasis is being placed on mutation [2-4], 
rearrangement [5], amplification [6-8], and 
demethylation [9] of oncogenes that are 
supposed to represent the primary events 
leading to oncogene activation when car-
cinogens trigger neoplasia in animals or 
humans (the reader is referred to ref. [10] 
for more extensive details on this topic ). 
The data underlying this supposition were 
mainly derived from experiments per-
formed with tumor cells in vitro. In vivo 
studies on this issue are rare. 
A model which has proven to be suitable 
for such in vivo studies is Xiphophorus7 i.e., 
a fish genus from Central America known 
as the platyfish and swordtails [11]. All in-
dividuals of this genus carry an oncogene, 
designated Tu~ which was analyzed by for-
mal genelies long before the viral and 
cellular oncogenes were identified by 
methods of modern molecular biology [ 12 
-16]. Our phenogenetic, cytogenetic, and 
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developmental genetic studies on Xipho-
phorus, however, have failed so far to detect 
any structural alterations of the Tu onco-
gene which were expected to occur when 
the gene switches over from the silent to the 
tumorigenic state. In contrast, it appears 
that impairment of the Tu oncogene ~i~t 
reduce tather than promote its tumongeruc 
potential and, therefore, it is difficult to de-
tect. 
By means of seven experiments the pres-
ent study aims to show that the common 
primary events in the causation of neopla-
sia in Xiphophorus are changes in the regu-
latory gene systems controlling the on-
cogenes rather than changes in the on-
cogenes themselves. 
B. Tbe Oncogene aod the Neoplasm Used 
in This Study 
I. The Oncogene 
It appears that the genetically identified 
oncogene Tu may mediate neoplastic trans-
formation in poorly differentiated cells of 
all tissues. The type of tissue in which tra~s­
formation occurs (for instance in the ptg-
ment-cell system) depends on regulatory 
genes of Tu. Oncogenes other than Tu 
which were expected to exist in Xiphopho-
rus were not detected by genetic methods 
(for discussion oftbis problern see [16]). 
From the eleven cellular oncogenes (~­
oncs) that were identified molecularly tn 
Xiphophorus (c-erb, c-src, c-myc, cfgr~ 
c-ab/, c-fes, c-myb, c-rasH, c-rasx, c·sis, 
c-yes) [16] only c-src will be taken into con-
siderati<:n beca.use rnost of our knowledge 
comes from th1s gene. Its inheritance was 
identified by molecular hybridization of vi-
ral src probes with genomic Xiphophorus 
DNA, ~nd its activity was monitared by the 
t:a.nscnpt and by the pp6oc-src kinase ac-
llVIty assayed according to Collet and Erik-
?on [ ~ 7]. lhe results parallel comp1etely the 
tnhentance and phenotypic expression of 
the Tu oncogene, speci fied by tumor devel-
opment [I, 18-20). 
H. lbe Neoplasm 
()ut of the 25 different types of neurogenic 
(neuroblastoma, melanoma, etc.). mes-
enchymal (fibrosarcoma. reticulosarcoma, 
etc.), and epithelial (adenocarcinoma. 
hepatoma, etc.) neoplasms tha t have been 
induced and identified in Xiphophorus only 
melanoma is takcn into consideration in 
this study. This tumor has the advantage 
over the tumors of other histogenesis in 
that its development can easily be traced 
from a single transformed pigment cell de-
tectable by its typical heavy black pig-
mentation, up to the extreme malignant 
melanoma that is lethal (Fig. 1 ). 
C. Results and Discussion 
I. First Experiment: Tumors lnduced 
by Dislocation of Regulatory Genes fbr 
the Oncogene in a Germ Line Cell 
Information about the crucial event in the 
causation of this type of hereditary mela-
nonla cornes from an X-ray-induced struc-
tural chromosome change involving a 
translocation of the Tu oncogene from the 
X chromosome of Xiphophorus maculatus 
(platyfish) to an autosome of Xiphophorns 
helleri (swordtail) and the corresponding 
Tu deletion that took place in meiosis of an 
F1-hybrid female ( 13) (see Fig. 2 a-d). In its 
new position (Fig. 2 c) Tu is no Ionger con-
trolled by its formerly linked regulatory 
genes that act only in the cis position ( 13). 
A powerful regulatory gene nonlinked to 
Tu that acts in the trans position persisted 
in the system. Fertilization of the egg \vith 
spenn of the swordtail and breeding the 
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Fig. 1 A-C. Development of a somatic mutation-
conditioned melanon1a. A Cell done consisting 
of eight transformed melan<X)'tes; B Clone con-
sisting of some hundreds of transformed melan-
oblasts and melanocytes; C Lethai mafignant 
melanoma 
mutant using thc swordtail as the recurrent 
parent resulted in off..~pring in which all 
animals containing the Tu translocation 
segregated into a I : l ratio of animals lack-
ing or containing the nonlinked regulatory 
gene for Tu. _ 
In both segregants, as a consequence ot 
the Iack of the linked regulatory genes. 
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Fig.la-f. •~ Translocation ofthe Tu oncogene 
from the X chromosome (X) of X. maculatus to 
an autosorne (A) of X. helleri and d the respec-
tive Tu deletion. Note separation of Tu from its 
linked regulatory genes RM~I and Rco (see first 
experiment of this study); e X chromosome of X. 
maculatus that is used in the second experiment 
(see Figs. 5, 9); f The X chromosome used in the 
third experiment (see Fig. 10). Note that e and f 
differ only in the RM~I locus. F, female-sex-de-
termining region; Pter. pterinophore locus. Rco 
region containing at least 13 compartment-spe-
cific regulatory genes such as RPp (posterior 
part-specific) and RDJ(dorsal fin-specific); RMe/, 
melanophore-specific regulatory gene; Tu, onco-
gene 
neoplastic transformation takes place in the 
pigment-cell precursors of the early em-
bryo. In the segregants lacking both the 
linked and the nonlinked regulatory genes, 
neoplastic transformation continues in pig-
ment-cell precursors in aU areas of the 
body, thus forming a '•whole body mela-
nomau (Fig. 3 B) which kills the fish before 
or shortly after birth. If, however, the non-
linked regulatory gene is present in the sys-
tem, melanoma development is retarded at 
the time of birth (Fig. 3C). The fish de-
velop melanoma but may reach sexual ma-
turity, thus providing the possibility to 
breed by further backcrosses with X. hel-
leri, a stock that continuously produces 
lethal-melanoma-developing and non-
lethal-melanoma-developing embryos. If, 
furthermore, the regulatory gene is in-
troduced into the system in the homo-
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zygous state, no Tu-~ediated. melanoma 
develops (Fig. 3A). F1sh ca~1ng the Tu 
deletion chromosome (see F1g. 2 d) have a 
highly diminished potential for the forma-
tion of all kinds of neoplasms. 
The development of the whole body mela-
noma in the early embryo reflects the genu-
ine oncogenic effect of the completely de-
regulated Tu on the pigment-cell s~stem. 
These observations suggest to us that m the 
early embryo Tu n~rmally. ex.erts im~rta~t 
functions in cytodtfferentiahon, which, tf 
Tu is completely deregulated, cannot be 
stopped (see below). 
So far we have not tested pp6oc-src kinase 
activity in the embryos that develop ~e~a­
noma. However, pp6oc-src kinase act1~1ty 
was measured in the normal developmg 
embryos (Fig. 4) [21]. The activity is detect-
able from the very outset of cleavage and 
strongly increases during early organ~gen­
esis. While organogenesis morphologtcally 
culminates, kinase activity apparently be-
comes choked, decreases during the growth 
phase before and after birth to a lower 
Ievel, and thereafter (not shown in Fig. 4) 
remains constant at a basic level through-
out the whole life of the fish [ 19). In adults 
it was found that pp6oc-src kinase activity is 
organ specific, with the brain always show-
ing the highest values [ 18, 19]. The resu~ts 
suggest that c-src activity is related to dtf-
ferentiation and specificity of organs rather 
than to cell growth. Similar sequ~nces of 
pp6oc-src kinase activity during life w~re 
found in frogs and chickens (see Fig. 4), In-
dicating that our results are more general 
rather than fish specific [21 ]. 
These genetic, em bryological, and 
molecular biological observations suggest 
to us that the melanoma-mediating onco-
gene, irrespective of its appearance a~ Tu or 
c-src, exerts important nonnal functtons as 
a developmental genein the early embryo. 
Moreover, we assume that in normal em-
bryogenesis these functions become 
switched off or choked by regulatory genes 
after cell differentiation progresses to or-
ganogenesis. If, however, the regulatory 
genes (i.e. the entire choke in the Iethai Tu 
translocation) are Iacking, the oncog~ne 
continues to exert its early embryo-spectfic 
functions which, as an extension of tbe 
cellular development in the early embryo, 
A 
B 
c 
appear as neoplastic transformation. Sup-
port for this idea comes from the high 
pp60''-src kinase activity that is found in the 
melanoma of young and adult fish ( see sec-
ond and third experiments). In any case, 
th~ crucia1 event leading to neoplasia in 
thts experiment is the X-ray-induced 
translocation-condi tioned loss of oncogene-
specific regulatory genes. 
II. Second Experiment: Tumors lnduced 
by c:rossing-Conditioned Elimination 
of Regulatory Genes for the Oncogene 
from the Germ Line 
The basic crossing procedure tor the pro-
duction of melanoma-developing )(ipho-
pl~orus. is shown in Fig. 5: Crosses of a 
wtld platyfish female from Rio Jamapa 
(Fig. 5 A) with a wild swordtail male from 
Ri? Lancetilla (Fig. 5 B) result in F1 hybrids (~t~. 5 C) that develop uniformly in all in-
dtvtduals, with melanomas consisting 
mainly of well-differentiated transformed 
Fig. 3 A-C. Backcross 
hybrids (X. rnacularus X X. 
helleri X .:r. helleri) carrying 
the Tu translocation ac-
cording to Fig. 2 c. A A 
nonlinked regulatory gene 
is present in the homo-
zygous state. 'There is no tu-
mor; B Thc nonlinked 
regulatory gene is Jacking. 
Lethai '"whole body mela-
noma" develops; C One 
copy ofthe nonlinked regu-
latory gene is present 
Melanoma devclops but the 
animals reach sexual ma-
turity. A Adult fish. 5 cm 
long; B, C nconates, 6 mm 
Iong 
pigment cells that are rnorphologically 
similar to those of certain spots of the 
parental platyfish. They occur only in those 
cotnpartments of the body where the 
platyfish parent infrcq ucntly exhibits the 
spots. e.g., in the skin of the dorsal f1n and 
the posterior part of the body. In older F1 
animals. the compartment-specific mefa-
nomas combine to torn1 a large benign 
melanoma. Backerosses of the F 1 hybrids 
with the swordtail as the recurrent parent 
(Fig. 5 D) result in ollspring (BC1) exhibit-
ing three typcs of segregants: 25S'f, of the 
BC1 (Fig. 5 E) develop benign melanoma 
like that of the F1 , 25% (Fig. 5 F) develop 
malignant n1elanoma consisting mainJy of 
incompletely ditferentiated transformed 
cells which invade other tissues (except for 
brain, gonads. intestine) and eventually kill 
thc fish, whereas 50% ( Fig. (i~ H) de"'elop 
neither spots nor melanomas. Further 
backcrosses (not shown in Fig. 5) of thc fish 
carrying benign rnelanoma with the sword-
tail result in a BC2 that exhibits the same 
segregation pattem as the BC1 • The same 
applies for further backcrosses of this kind. 
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Fig. 4. pp60'·-src Kinase activity during cleavage, 
organogenesis. and growth. Data from [21] 
Backerosses of the fish carrying the malig-
nant melanoma with the swordtail show a 
different result: 50% of the BC segregants 
develop malignant melanoma, whereas the 
remaining 50% are melanoma free; benign 
melanomas do not occur. Whenever mela-
nomas occur in these crossing experiments, 
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they develop in both the com partment of 
the dorsal fin and the compartment of the 
posterior part of the body. 
The results obtained in this crossing ex-
periment (and a large vari~ty of similar ex· 
periments) may be exl?latned by .the as-
sumption of four promtnent genettc com· 
ponents that are involved in melanoma for-
mation or protection from J?elanoma, re-
spectively. They are co~tnbuted by X. 
maculatus (for those contnbuted by X. hel-
/eri but not involved in melanoma forma-
tion in this crossing experiment, see below) 
and are normal homozygous constituents of 
the natural gene pool of the wild platyfish 
population from Rio Jamapa. Three of ~he 
genetic components (see the followtng 
points 1, 2, 3), as was confirmed ~y about 
70 structural changes, are closely hnked to-
gether at the end of th~ X ch~omosome (see 
Fig. 2). The fourth (potnt 4) ts autosomally 
located. 
I. The Tu oncogene. This gene is appar-
ently responsible for neoplastic transforma-
tion. The restriction of neoplastic transfor-
mation to pigment cells and to the devel-
opment of melanoma in the dorsal fin and 
in the skin of the posterior part of the body 
comes from other genes. 
2. The regulatory gene R Mel· I rnpai~met.tt 
oftbis gene (R'Met) specifies the tumongenic 
effect of Tu to the melanophore system. 
RMel is a member of a series of tissue-spe-
cific regulatory genes which, in the. im-
paired state, determine the histogenes1s of 
the tumors ( mesenchymal, epitheli~l, and 
neurogenic neoplasms). The muta~Io~s of 
these genes indicate that tissue spectfictty of 
neoplasia depends on regulatory genes 
rather than on oncogenes. 
3. The regulatory genes Rpp and Rot· lm-
pairment of these genes (R'pp, R'vt ~ per-
mits the development of melanoma tn the 
skin of the posterior part of the body (Pp) 
and in the dorsal fin ( Dj) provided tha t 
RMel is also irnpaired. Thirteen com-
partments of the body (anal fin, tail fin, 
mouth, eye, peritoneum, meninx, etc.) t~at 
have been identified correspond to a senes 
of different regulatory genes (Rco in total) 
which in turn correspond to sites of the 
body where melanomas may occur (see 
Fig. 13). 
c-src 
A 3oo 
• 
Csoo 
F Boo 
Fig. ~A-H. Crossing procedure for the pro-
d~ctton of melanoma-developing hybrids of 
Xzphophonts. A X. rnaculatus from Rio Jamapa 
(Mextco); some small spots in the skin of the 
dorsal tin and the side of the hody are visible. 
The spots consist of terminally diflercntiatcd, neo-
plasticaUy transfbrmed pigment cells. B X. helleri 
from Rio L.ancetilla (Mexico), aJv..·avs lacking the 
sr.ots. C F1, developing benign meh1~oma in;tead 
ot spots ( l 00% of the Ft). D X. helleri from B 
used in the backcross as the recurrent parent. E 
Backcross hybrid with benign melanoma (25f'f, of 
the BC generation). F Backcross hybrid with 
m~lignant melanoma (25% of the ~BC gencr-
atton). G" H Backcross hybrids that do not de-
velop melanon1a (50% of the BC generation). 
Spots and melanomas (in the posterior part of 
the body and the dorsal fin) depend on the de-
regulated Tu of the X chromosome shown in 
~~·ig. 2 e. Depending on the pterinophore locus 
(Pter ofthis chromosome), spotted and tumorous 
fish (A, C, E and F) exhibit a reddish coloration. 
pp60c-:rc Kinase activity expressed as counts/min 
per m•lligram protein; note basic and excessive 
activity and correlation between c-src expression 
a?d Tu expression. Data trom [15. 191 were com-
btned. See Figs. 9 and 10 
c-src 
B 3oo 
0 3oo 
G1oo 
H Joa 
4. The ditTerentiation gene DijJ 'Ibis 
gene is indicated by the l : 1 segregation of 
bcnign- and n1alignant-melanon1a-bearine. 
fish. lf it is present. the rnajority of th~ 
n1elanoma cells are weil ditlerentiated (be-
nign melanotna). u: however, D~!.l is lack-
ing. the n1ajority of the melanorna cells are 
poorly differentiated (nullignant nlela-
noma). 
Additional regulatory genes contributed 
by the platyfish to the hybrid genome have 
been identif1ed but are considered only in 
general in this experiment. · 
Xiplwphorus helleri also contains the Tu 
oncogene and presunutbly the linked regu-
latory genes, which. ho\\'evcr, are not mu-
tated and thus are fully active. Tu and its 
linked regulatory genes. therefore. are not 
detectable 'vith the methods used in this 
experiment. Furthermore. since the linked 
regulatory genes act only in the cis position. 
this Honcogene-regulatory-gene complex:~ 
contributed by the swordtail. does not sig-
nificantly intluence the expression of the 
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platyfish-deri.ved n1elanoma-mediati~g Tu 
copy. No DifJ and nor any other nonhnked 
regulatory genewas found in the swordtail 
that might correspond to those of the 
platyfish. 
The outcome of this crossing experiment 
suggests the following interpretation: FoJ-
lowing crossings and backcrossings accord-
ing to Fig. 5, the regulatory-gene-carrying 
chromosomes of the platyfish are re-
placed stepwise by the homologous chro-
mosomes of the swordtail, resulting in the 
gradual disintegration of the regulatory 
gene system for the platyfish-derived 
Tu. Thus the Tu hybrids spontaneously 
develop benign melanoma if some 
regula tory genes such as Diff are still pres-
ent in the genome and maJignant mela-
nonla if the regulatory genes are lacking. lf 
the platyfish-derived Tu is lacking, no 
melanomas occur. 
Basedon the assumption tbat the activity 
of the pp6oc~src_associated phosphokinase 
monitors the activity of the c-src oncogene, 
we carried out comparisons between kinase 
activity, i.e .• c-src expression, and tumor 
development, i.e., Tu expression. The pre-
paratory work to this study sbowed that 
pp6oc-src kinase activity in normal tissues of 
nontumoraus and tumorous fish is tissue 
specific~ with the brain always showing the 
highest values [18]. It furthermore showed 
that this activity is elevated in the brain of 
benign-melanoma-bearing fish, and even 
higher in the brain of malignant-mela-
noma-bearing fish. In any case, pp6oc-srt· ki-
nase acti vity varies in both melanoma and 
the brain in the same direction. Hence, we 
were able to determine pp6oc-src_associated 
protein kinase activity mainly in brain ex-
tracts and relate the activity observed to tbe 
expression of Tu ascertained by the devel-
opment of melanoma. The possibility that 
the differences in kinase activity measured 
in the fish of different Tu genotypes are due 
to secondary processes in the melanoma 
appears unlikely. Theretbre, the results re-
flect the actual genetic activity of the c-src 
oncogene in the nontumorous brain tissue 
ofthe tumorous and nontumorous fish. For 
critical evaluation of the methods see refs. 
[18, 19l 
As indicated in Fig. 5, the purebred 
platyflSh female (Fig. 5 A) carrying the pop-
234 
ulation-specific ' 4 Tu-regulatory-gene com-
plex" in both of its X chromosomes, as weil 
as the purebred swordtail and the BC 
hybrids lacking this special complex, dis-
play the same activity of c-src kinase. We 
interpret this activity tobe the basic expres-
sion of c-src. In contrast, the melanoma-
bearing hybrids which contain the de-
repressed Tu show an increase in c-src ac-
tivity, with the malignant-melanoma-bear-
ing BC hybrids displaying the highest ac-
tivities. 
To accomplish the crossing experiment 
(not shown in Fig. 5) we crossed two mela-
noma-bearing BC hybrids ( F x F) that ex-
ceptionally reached sexual maturity. The 
resulting Tu/Tu hybrids (25% of the off-
spring) are of special interest. They show an 
oncogene dosage effect in both melanoma 
formation and pp6oc-src kinase activity as 
compared with the parental BC hybrids [ l, 
20]. 
In summary, aU experiments of this kind 
showed a clear-cut correlation between 
c-src expression (measured by pp6oc-src ki-
nase activity) and Tu expression (measured 
by melanoma formation). 
Many features that are assumed to be "in-
volved in the causation of neoplasia have 
been found in melanoma of Xiphophorus. 
About 70% of the melanomatous cells in 
ceU cultures derived from embryos exhibit 
at least two pairs of double minute chromo-
somes (Fig. 6) [22) that might be interpret-
Fig. 6. Meta_phase sbowing double minute chro-
mosomes {DM). DMs were always found in 
cell cultures derived from melanomatous em-
bryos (22) 
MUSCLE 
Fractions 
ed as carriers of amplified oncogenes [7~ 8). 
Virus particles have been found in the 
melanoma following treatment with 
bromodesoxyuridine [23]. FoUowing su-
crose density centrifugation, in the super-
nataut of nontreated melanomatous cells of 
cultures me:n tioned above, RNA-dependent 
DNA polymerase associated with partides 
similar to fish iridovirus [24J (Fig. 7) was 
found in the density range of 1.15-1.17 g/ml. 
Fig. 7. Virus particle 
(iridovirus-like [24]). These 
particles were always found 
in the supernatant of celi cul~ 
turcs mentioned in the legend of 
Fig. 6 
Fig. 8. RNA-dependent DNA polymerasc ac-
tivity in Xiphophorus. Sunose density gradient 
centrifugation of the microsomal pellet 
Three to five particles have been count-
ed per grid, which is equivalent to lOS 
particles/ml. RNA-dependent DNA poly-
merase activity has also been detected in 
the melanoma tissue and~ although three to 
five times lower, in the musde (Fig. 8). 
Activity of many other enzymes. such as 
tyrosinase [25}, Iactate dehydrogenase [26, 
27), malate dehydrogenase, and pyruvate 
kinase [27]~ is changed in the melanoma. 
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Table I. SCE frequency in Xiphophorus Meta- Cells Range Mean SCE/ intestinal cells of Xipho· 
phorus (29] phases with 
(SCE/ metaphase 
scored SCE (%) cell) (SE) 
X. maculatus 
Tu I Tu; Dif/1 Diff 131 31.9 0-3 0.41 ±0.05 
X. he/leri 
-/-;-/- 166 32.0 0-3 0.40±0.03 
Hybrids carrying melanoma 
Ft: benign 
Tu! -; Dif/1- 153 56.8 0-4 0.82±0.05 
BC: benign 
Tu/ -;Diff!- 113 61.9 0-4 0.97±0.09 
BC: malignant 
Tu/-; -I- 137 66.5 0-4 0.92+0.10 
BC hybrids carrying no melanoma 
33.6 0-3 0.38±0.03 
-I- ~·Diffl-
-1-;-1-
Sister . chromatid exchange (SCE) is ele-
~ate~ tn melanoma cells [28]. Interestingly, 
Jts h1gh frequency is in parallel with that of 
nontumoraus intestinal cells of melanoma-
taus fish., and is low in intestine ofthe non-
melanomatous fish (Table 1) [29]. This is 
a striking similarity to the parallels of 
pp6oc-src kinase activity measured in the 
melanoma and in the healthy brain. 
. Thes~ fac~ors and many others not men-
!-Ioned tn thts study are certainly important 
m melan~T?a format_ion, but probably none 
of the~ ts n~v~lved tn the primary event of 
tumongenests 1n tbis ~x~~~en~. The pri-
mary event of tumor tnttiation m this ex-
periment, without any doubt, happens 
when the egg and sperm contribute a nor-
mal set of oncogenes to the zygote but fail 
to contribute the adequate regulatory gene 
systems f~r control of the oncogenes. The 
confirmat1on of this view comes from the fi-
~al cr~ssin_g series of this experiment out-
hned tn F1g. 9: Backerosses of malignant-
m_elanoma-:bearing hybrids (Fig. 9 A) (i.e., 
Ftg. 5 F) ~1th the platyfish (Fig. 9 B) (like 
th~e of Ftg. 5 ~ but containing the Tu de-
leüo~ according to Fig. 2 d) result in a 
q~ ': 1 tbat segregates in 50% of animals 
dtsplaytn!? ~nign m.elanoma (Fig. 9 C) and 
501, exhibtung ne~ther melanomas nor 
spots (not shown in Fig. 9). Further 
~kcross~ of the benign melanoma bear-
mg quas~-F1 hybrids with the platyfish 
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188 
145 38.7 0-4 0.47±0.04 
Fig. 9A-H. Crossing procedure for the suppres-
sion of melanoma in Xiphophorus. A Malignant 
melanoma-bearing backcrosshybrid according to 
Fig. 5 F. B X. maculatus according to Fig. 5 A as 
the recurrent parent. C Quasi F 1 -exhibiting be-
nign melanoma. D X. maculatus as the recurrent 
parent. E-H Backcross bybrids (quasi X. macula-
tus) exhibiting spots only. Melanomas and spots 
depend on Tu of the X chromosome shown in 
Fig. 2 e. See Fig. 5 
(Fig. 9 D) result in spotted and nonspotted 
fish th~t are similar to the purebred platy-
fish (F1g. 9E-H). Genetically they segre-
gate into those that inherit the capability to 
develop melanoma after crossings with 
swordtails and those that do not inherit the 
capability to develop melanoma (not 
shown in Fig. 9). The outcome of this final 
se~es of backcrosses indicates the stepwise 
reintroduction of the platyfish chromo-
somes carrying the regulatory genes for the 
oncogene 1nto the descendants, and the re-
construction ofthe original regulatory gene 
system tbat suppresses the activity of the 
oncogene in the platyfish genome. 
~ig. lOA-H. Crossing procedure for the produc-
t:Jon. of Xiphophorus hybrids that are sensitive to 
carcmogens. The procedure is basically the same 
as that outlined in Fig. 5 (A X. maculotus; B X. 
helleri~ CF.; D X. helleri). A, C, E, and F exhibit 
~ reddish ooloration. c-src, pp60 c-.rrc IOnase activ-
Ity. See text 
8 
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Presumably the oncogene itself remained 
unchanged during the crossing procedure 
(Figs. 5~ 9) that first induced and thereafter 
suppressed melanoma forrnation. Car-
cinogens or tumor-suppressing agents were 
not required in this experiment. The out-
come of the experiment, however, indicates 
that the experimenter must interfere in the 
regulatory gene system of the oncogene to 
be able to induce or suppress melanoma 
(or any other neoplasm). To examine this 
idea. we carried out the following exper-
iment 
lll. Third Experiment: Tumors lnduced 
by lmpairment of Cell-Type-Specific 
Regulatory Genes for the Oncogene 
in Somatic Cells 
This experiment is based on the two as-
sumptions that (a) the total nurober ofpig-
ment-cell precursors competent for neo-
plastic transformation is 106 (this is the 
average number in tbe pigment-ceU system 
of a young fish) and (b) the mutation rate 
for a given gene in these cells is l Q-6. Then 
tumor incidence. is one (on average 100% of 
the treated animals develop .()ne tumor) 
provided the oncogene is under control of 
only one. regulatory gene~ lf, however, the 
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Fig. 11 ~ 8. Backcross 
hybrids according to 
Fig. 10 E and F after treat-
ment with MNU. A Diff-
carrying segregant (iden-
titied'by an esterase) de-
veloping benign mela-
noma; B DijJ-lacking 
segregant (identified by 
lack of the esterase) de-
veloping malignant mela-
noma 
oncogene is regulated by two genes, the 
rate of simultaneous mutations of both 
regulatory genes in one cell is 10-12 and ~he 
tumor incidence is 1 Q-6. This calculauon 
shows that if the oncogene is controlled by 
more than one regulatory gene, it . is dif-
ficult to succeed in inducing somauc mu-
tation-conditioned neoplasms at a frequen-
cy suitable for m utagenesis experim~nts. . 
To establish a Xiphophorus stratn .suit-
able for mutagenesis studies on a Single 
regulatory gene of the Tu oncogene, we re-
placed the R'pp R01 R'Mel platyfish X chro-
mosome used so far (Fig. 2e) by the R'pp 
Rf>t RMel Tu X cbromosome (Fig. 2 t), 
whtch, instead of the impaired RMeb con-
tains the normal R Mel· Crossings were per-
formed according to Fig. 10, which are es-
sentially the same as those described ~n the 
first part of the previous expenment 
(Fig. 5). 
Due to the active RMel that controls the 
oncogene in the pigment cell system, no 
melanomas develop in the hybrids. The BC 
hybrids E and F that correspond to the 
melanoma-developing BC hybrids in. the 
former experi.ment (they can be reco~niZed 
by a reddisb coloration encoded 1n the 
pteridine mark.er gene Pter also linked to 
the Tu oncogene; see Fig. 2) are, however, 
sensitive to carcinogens and may develop 
~abl': 2. Tumor initiati<:>n (som~tic mutation) and promotion (promotion of cell differentiation) dis-
tingu1shed by tester strams of Xtphophorus constructed according to the third and sixth experiments 
Agents Dose Period Initiation Promotion 
Survi- Tumors Survi- Tumors 
vors (%) vors (%) 
MNU I OS ~g/ Ii ter 5 X 14 days 45 min 457 88 (19) 36 18 (50) ENU 105 J.tg/liter 5 x 7 days I h 235 21 (9) 21 2 ( 10) Diethylni trosamine 45 X I 03 ~g/liter 2X /week 23 2 (9) 24 0 
for 8 weeks 
TP A (in D MSO) I ~g/liter/day 10 weeks 121 0 23 11 (48) 4-0-Methyl TPA I ~g/liter/day 10 weeks 20 0 15 0 DMSO 2 X 106 J.tglliter/8 days 10 weeks 98 0 12 1 (8) Diazepam 500 ~g/liter/day 48 weeks 27 0 24 0 
Phenobarbital 7.5 X 1Q3 ~g/liter/day 10 weeks 25 0 11 7 (64) Cyclamate 106 J.Lg/liter 8 weeks 28 0 22 12 (55) 
2 X I06 ~g/liter 8 weeks NT NT 10 6 (60) Saccharin 5 X I06 ~g/liter IO weeks 21 0 23 3 ( 13) 5-Azacytidine 1.25 x 103 J.tg/liter/day 8 weeks 47 0 12 7 (58) 
L-Ethionin 500 J.tg/liter/day 8 weeks 18 0 16 0 
Actinomycin D 20 J.Lg/liter/day 8 weeks 15 0 10 0 
Testosterone 2-20 J.Lg/liter/day 24weeks NT NT 22 22 (100) 
Methyltestosterone 2-20 J.tglliter/day 24 weeks 113 0 30 30 (100) 
5-Dihydrotestosterone 2-20 J.Lg/liter/day 24weeks NT NT 11 11 (100) 
Methylandrostenolone 2-20 J.tg/liter/day 24 weeks NT NT 21 21 (100) 
Es trogen 2-20 J.tg/liter/day 48 weeks NT NT 5 0 
Diethylstilbestrol 2-20 J.tg/liter/day 48 weeks NT NT 16 0 
17-H ydroprogesterone 2-20 J.lglliter/day 48 weeks NT NT 9 0 
Progesterone 2-20 ~g/liter/day 48 weeks NT NT 8 0 
X-rays IOOOR 3X45 min/6 week 805 163 (20) 45 45 ( 100) 
interval 
DMSO, dimethylsulfoxide; NT, not tested. Data were compiled from theses of C.-R. Schmidt, A. 
Schartl, A. Herbert (Univ. ofGiessen) 
melanoma after carcinogen treatment. 
Those BC hybrids carrying the Diff gene 
(autosomal; identified by a D!ff-linked es-
terase marker gene [30, 31]) may develop 
benign melanomas and those lacking Diff 
may develop malignant ones ( see Figs. I, II ). 
Crosses between two BC hybrids of the lat-
ter genotype were the basis for the es-
tablishment of a strain homozygous for the 
R'pp R'nt R Mel Tu chromosome [32, 33]. Be-
cause each of the two copies of the Tu 
oncogene is repressed by its own linked 
R Mef, which acts in the cis position only, 
the incidence of animals developing mela-
noma following treatment with carcinogens 
potentially doubles. These fish are highly 
suitable as test animals for mutagenic car-
cinogens in the water (Table 2, see column 
"Initiation"). 
In contrast to the crossing-conditioned 
hereditary melanomas that, due to their 
multicellular origin [15], cover large areas 
in the compartments of the body from their 
very beginning, the carcinogen-induced 
melanomas appear first as small foci of 
cells in these compartments (Fig. 1), in-
dicating that they originate from the ex-
pected single mutational event in a particu-
lar regulatory gene of the oncogene in a 
particular somatic cell in a particular com-
partment of the body. 
All purebred and hybrid animals of this 
experimentdisplayuniform pp6oc-.sn- kinase 
activity in the brain [ 19]. This activity seems 
to represent the basic c-src expression 
like that of the nontumorous fish in the 
previous experiment ( cf. Figs. 5, 1 0). Fol-
lowing the induction of melanomas and of 
any other kind of neoplasia, pp6oc-src 
kinase activity in the brain remains un-
changed. Kinase activity in the melanomas, 
however, is heterogeneous, with the malig-
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d p6oc·src Table 3. Elevate p 
kinase activity in Xipho-
phorus bearing tumors as 
compared with nontumor-
ous controls 
Tumor 
Hereditary 
Elevation ofkinase activity 
In tumors In brain 
Melanoma, benign (n = 15) 
Melanoma, malignant (n = 13) 
+ 
++ 
+ 
++ 
Induced 
Melanoma, malignant (n =2) 
Melanoma, malignan t 
Melanoma, amelanotic 
++ 
+++ 
++++ 
0 
0 
0 
Retinablastoma (n = 2) 
Fibrosarcoma 
+++ 
++ 
0 
NT 
Fibrosarcoma +++ 0 
Fibrosarcoma 
Rhabdomyosarcoma 
Rhabdomyosarcoma 
+++++ 
+ 
++++ 
0 
NT 
0 
Epithelioma ++ 0 
Squamous-cell carcinoma ++ 0 
NT, not tested 
nant melanoma showing values that are at 
least as high as those of the corresponding 
melanomas of crossing-conditioned heredi-
tary origin. In an induced malignant 
amelanotic melanoma pp60c-src kinase ac-
tivity was even six times higher than that of 
the brain. As in melanomas, elevated Ievels 
of kinase activity were also found in other 
carcinogen-induced neoplasms such as fib-
rosarcoma. retinoblastoma, and epithelio-
ma (see Table 3). However. changes in the 
pp6oc-srt· kinase activity in the brain that are 
typical in the hereditary tumor-bearing ani-
mals were not observed. More sturlies are 
necessary to find out whether the elevation 
of pp60'·-src activity found in the neoplasms 
is due to the same impaired regulatory 
gene that pennits the Tu oncogene to me-
diate carcinogenesis. 
IV. Fourth Experiment: Transfer ofthe 
Regulatory Gene-Dependent Tumorigenic 
Potential by Genomic DNA 
To perform this transfection experiment we 
used different laboratory stocks of X. macu-
latus as donors. These stocks were uniform 
with respect to Tu and the impairment of 
the compartment-specific regulatory genes 
RAp and Rpp (se~ fifth experiment). They 
were. however, dtfferent in the cond.ition of 
the melanophore-specific regulatory gene 
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RMeh which was normal, impaired. strongly 
impaired, or deleted (Fig. 12). Total ge-
nomic DNA of the donors was injected into 
the neural crest region of early embry:os 
(where the pigment-cell precursors ong-
inate) of X. hel/eri. This species has ex-
cellent potential for expressing a deregulat-
ed oncogene (see previous experiments). If 
a donor containing the normal Rfl1er:Tu 
complex (Fig. 12 A) was used, no rec1p1ent 
exhibited transformed pigment cells. lf a 
donor strain was used that carried a Tu 
slightly derepressed in the pigment-cell sys-
tem by a "weak'' mutation of its linked 
RMef, i.e., RMel Tu (Fig. 12 B), then 0.4% of 
the recipients developed colonies of neo-
plastically transformed cells. If the D NA 
originated from a strain that carries the Tu 
derepressed to a greater degree, due to a 
'' " . f R . R" stronger mutatton o Mel· t.e.. Met 
(Fig. 12 C), the incidence of recipients 
exhibiting transformed pigment cells in-
creased to 2.6%. If, fmally, a donor was used 
in which the Tu Iacks the RMel (due to a 
chromosomal translocation) (Fig. 12 D), 
this incidence increased to 6.3%. DNA from 
animals carrying additional but rigidly r~­
pressed accessory Tu copies (not shown tn 
Fig. 12) did not influence the incidence of 
transforman ts [34 ]. 
Besides the fact that the information for 
neoplastic transformation, presumably the 
Donors No. of Recipients 
Phenotype Chromosomes Survived Showing 
Tr cells 
X R,\Je(!..l!. 
yRMe!Tu 2 010 0 
x R','vtf:Ll!!.. 
y .!!:.Mt,l.I!! 535 
X R"Me! Tu 
y R"Me!Tu 1 052 27 (2.6%) 
A -- .. Lu 
A -· .. ·-·D! I 032 65 (6.3'if.) 
DNase degraded 
DNAofC and D 
Fig. llA-D. Transfeetion activity ofdonor DNA 
extracted from male gonads of fish differing in 
Tu control by the pigment-cell-specific regu-
Iatory gene RMel· Data from {34). Seetext 
oncogene itselt: was transferred via total 
genomic DNA, it is important to note that 
the transforming donor DNA did not orig-
inate from tumor cells but from the non-
neoplastic testes, indicating that oncogenes 
must not necessarily be changed or ampli-
fied in order to acquire the transforming 
potential. The many oncogene transfection 
experiments accomplished during the past 
years by several authors with other systems 
in which DNA extracts from tumors were 
used [2, l, 35-37], with the expectation that 
tumor DNA differs from DNA from nor-
mal tissues, should be., in our opinion, re-
considered from the viewpoint of repres-
710 0 
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sion and derepression of oncogenes exerted 
by intact and defective regulatory genes. 
The main factors responsible for neoplasia 
are, in view of our results on Xiphophorus. 
not the onc genes, but their regulatory 
genes. 
This view is supported by the fact that 
the incidence of transformants, i.e., the 
inddence of transformation events me-
diated by Tu~ was independent of the nuro-
ber of Tu copies in the donor DNA (we 
tested DNA containing up to eight copies), 
but was exclusively dependent on the de-
gree of impairment of RMel· In this light it 
also appears reasonable to assume that 
R Meb if present, is so dosely linked to Tu 
that both Tu and RMe1 are always cotrans-
ferred [34]. 
Although the donor DNA originated 
from fish exhibiting different degrees of Tu 
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expression, the transformed cells of the re-
cipients all looked alike, and t~e cell ~o~o­
nies were all about the same siZe. Th1s m-
dicates that growth of the tumor is in-
fluenced neither by Tu nor by the intact or 
impaired R Mel· 
V. Fifth Experiment: Tumors Induced 
by Impairment of Compartment-Specific 
Regulatory Genes for the Oncogene in 
Germ Line Cells and/or in Somatic Cells 
The compartment-specific regulatory genes 
for the oncogene, designated Reo in total 
(see Fig. 2), have been studied mainly by 
means of X-ray-induced germ line mu-
tations that affect one or several sites of the 
crossing-conditioned melanomas (Fig. 13). 
These melanomas develop in BC hybrids, 
for instance (a) in the dorsal fin; (b) in the 
tail fm; (c) in both the dorsal fin and tail 
fin; (d) in the anal fin; (e) in the tail fin, 
dorsal fin, anal fin, mouth ti p, and pos-
terior part of the side of the body (mu-
tations of five compartment-specific regu-
latory genes are involved); (f) in the anterior 
and posterior parts of the side of the body; 
(g) in all compartments except for the 
mouth, belly, eye, dorsal fin, and tail fin; or 
(h) even in all compartments of the body. 
The phenotypes of additional combinations 
of impaired Reo genes have been described 
previously [13, 15, 16]. 
The compartment-specific distribution of 
these melanomas is inherited according to 
the segregation of the parental Tu-carrying 
chromosome, indicating that the respective 
R co genes are linked to Tu" and structural 
changes of the cbromosome have verified 
that this linkage is very close. At least 14 
genes corresponding to 14 different com-
partments have been identified. They rep-
resent regulatory genes that were desig-
nated RAp (anterior part), R/jl (posterior 
part), RD1 (dorsal fin), R 71 (tail fin), etc. in 
reference to each specific body com-
partment. Intact Rco genes repress Tu, and 
impaired Rco genes permit Tu activity. 
They act in the cis position only, indicating 
that the compartment-specific regulation of 
Tu exerted by the R co genes acts at the 
DNAlevel. 
In the activ~ state _th~ R Co genes appear 
to delay the diff'erentiabon of pigment cells 
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in the stem-cell stage (S-melanoblasts; see 
Rco in Fig. 14). Additional mechanisms 
that are not understood provide the fish 
with differentiating pigment cells that 
mostly escape neoplastic transformation, 
but very exceptionally may be transformed. 
If, however, one or several R co genes are 
impaired by mutation, ~mpartme.nt-spe­
cific melanomas develop 1n the hybnds and 
are inherited according to Mendelian pre-
diction. 
To study whether melanoma can also be 
induced by impairment of a compartment-
specific regulatory genein a somatic cell we 
carried out the following experiment: BC 
hybrids, which, due to the impairment of 
the pigment-cell-specific regulatory gene 
(R'Met) and of the dorsal-fin-specific regu-
latory gene (R[Jj), develop heredit_ary ~ela­
noma in the dorsal fin only, were Irradtated 
with X-rays. These animals frequently de-
veloped additional melanomas in other 
compartments of the body (Fig. 15) which, 
in contrast to the hereditary melanoma of 
the dorsal fm, are nonhereditary and de-
velop from small foci of transformed cells 
in the skin. 1his indicates a mutational 
event in a particular compartment-specific 
regulatory gene in a particular competent 
pigment-cell precursor in a particular com-
partment of the body. The oncogene it~elf 
that mediates neoplastic transformation 
probably remained unchanged. 
VI. Sixth Experiment: Tumors Induced 
by Promotion ofCell Differentiation 
The neutral crest cel/s of Xiphophorus which 
are, like those of all vertebrates, the pre-
cursors of different cell types, start migrat-
ing and differentiating at the outset of or-
ganogenesis in the embryo (Fig. 14) [3~, 
39]. Those entering their final locations m 
the skin and extracutaneous tissues become 
determined to differentiale to chro-
matoblasts. These chromatoblasts are the 
common precursors of all types of pigment 
cells (Chromatophores), including pterino-
phores, purinophores, and melanophores. 
Those chromatoblasts committed to differ-
entiale to melanophores give rise to stem 
melanoblasts (S-melanoblasts). These may 
reproduce throughout the life of the fish, 
N e Fig.13. Compartments for the development of melanomas in the fish. Mo, mouth; Ey, eye; Brn, brain membrane; Ap. anterior part: Df. dorsal fin: Pt. 
peritoneum; Af, anal fin; Sc, spinal cord; Pp, posterior part; Cr, crescent region: Pd. pedunde ofthe tail fin; Cf. caudal fin stripe; Tf. tail fin (see text) 
NORMAL MELANOPHORE 
PATTERN 
Homeostasls betweeD 
tbe different stages of 
cell dlfferentlatlon 
MALIGNANT AND BENIGN 
MELANOMA; SPOTS 
Different proportians of 
the different stages of 
cell dlfferentlatlon 
1 
Macropbages ~ 
Melanopbores ~ Tr-Melanopbores 
I 4 ..._ Diff ~ t ,, :-Melanooytes ....,- ~ Tr -Mel~ocyte:. ; g 
'JI t ........ I-gene• ~ , -
G-Melanoblasts _,., -- TrA-M.oblastsJ 
t o:VTri-MelaDoblast{) 
Q-lolelaDoblasts ~BMAT1 
§ 
oompetent 
~ Rco ; g 
Q-Melanoblasts 
• ~romatoblaste 
Neurat crest ® 
lolelanaphore /( 1 
i 
l g 
aystem 
Fig. 14. Schematic presentation of the differen-
tiation of normal and neoplastically transformed 
pigment cells. S -, 1-, and A -melanoblasts are 
stem, intermediate, and advanced melanoblasts, 
respectively. The Tr cells represent the tran.s-
fonned cells. Only I-melanoblasts are competent 
for neoplastic transformation. Tu, tumor gene 
(oncogene); RMel, regulatory gene for control of 
Tu in the melanopbore system; Rco, com-
partment-specific regulatory genes; g, ~~golden" 
gene that blocks pigment-cell differentiation; 
Diff, differentiation gene; I-genes, intensifier 
genes, which support prolifera tion of poorly dif-
ferentiated transfonned pigment cells. Macra-
phages attack melanophores and Tr-melano-
phores. Modified from [16] 
but may also differentiale to intennediate-
stage melanob/asts (1-melanoblasts) that 
continue ditferentiation to the advanced-
stage melanoblasts (A-melanoblasts) that 
can be distinguished from their precursors 
by their reaction to dopa. These celJs differ-
entiate to melanocytes, and these, finally, to 
melanophoreL Genetic, cytological, and ul-
trastructural studies of the differentiation of 
the pigment cells have shown tbat the 
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I-melanoblasts are the only cells of the sys-
tem tbat are competent to undergo neo-
plastic transformation, i.e., competent to 
undergo the transforming activity of the Tu 
oncogene [38, 39]. 
The 1-melanoblasts, after being trans-
formed to Trl-me/anoblast.s (all trans-
formed cells are called Tr cells) ditferen-
tiate to the easily recognizable, proli~erat­
ing TrA me/anob/asts. These Tr cells differ-
entiale to the heavily pigmented . Tr 
me/anocytes, whlch proceed to the termmal 
stage of differentiation of the transformed 
pigment cells, represented by the Tr 
melanophores (15]. 
We have an.alyzed several genes t~at. are 
involved in pigment-cell different1atton. 
One of these genes is the '"golden" gene 
(g+), which, if present as a mutation in the 
homozygous state (g/g), creates an almost 
complete stop of melanophore differen-
tiation at the stage of S-melanoblasts (see g 
in Fig. 14). The always present d~o­
sopterines become more visible in the skin, 
thus giving the fish the "golden" color-
ation. 
'Ihis g mutation was introduced into the 
~ereditary melanoma-bearing hybrids by 
hereditary 
/ 
Hg. 15. Fish exhibiting 
crossing-conditioned 
hereditary melanoma in the 
compartment of the dorsaJ 
fin and X-ray-induced S<)-
matic mutation-conditioned 
melanoma in the com-
partment of the posterior 
part of thc body (see Df and 
Pp in Fig. 13) . 
induced 
Fig. 16. Littermates that segregate into "golden" 
(g~ g) animals (leji) and tumor {g+ 1 g) animals 
(nght). The gl g animals are protected from 
~e~anoma by a block of pigment-cell differen-
~~tion in the stage of the stem melanoblasts (see 
I·tg. 14). Following treatment with promoters of 
ceU differentiation (see Table 2) they develop 
melanoma similar to their heterozygous lit-
termates 
introgressive breeding" i.e., by the replace-
ment of the g+ -bearing chromosomc by the 
g-bearing homolog. In animals hetero-
zygous for g (g I g +) the derepressed Tu 
oncogene still mediates melanoma forma-
tion (Fig. 16, right). In the littermates that 
are homozygous fbr g (gl g), however, no 
melanomas develop (Fig. 16, left): The 
block of differentiation at tbe stage of the 
stem melanoblasts exerted by the homo--
zygous g-mutation protects the fish from 
melanoma tormation or from the activity of 
its own derepressed oncogene. 
To break this protection mechanism we 
tested a large variety of mutagenic and 
norunutagenic agents. Most of these agents 
(see Table 2~ colun1n ~'Promotion n) pro-
mote almost simultaneously the differen-
tiation of large amounts of the non-
competent cells to the competent stage, 
whicb subsequently become neoplastically 
transformed and give rise to melanomas. 
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Fig. 17. Decrease of m5 dC methylation of DNA 
in Xiphophorus hybrids after treatment with 
2.5 mg/liter per day 5-azacytidine. Fish were 
treated for 3 months, beginning at birth. HPLC 
analysis (filling, Supelco 4C-18-DB). Untreated, 
six animals; treated, five animals [63] 
These tumors are morphologically similar 
to the spontaneously developing mela-
nomas of the glg+ littermates, develop in 
the same compartments of the body, and 
are, similar to all hereditary melanomas, of 
multicellular origin. X-rays, N-methyl-
N-nitrosourea (MNU), and N-ethyl-N-
nitrosourea (ENU), which are powerful 
mutagens or tumor initiators, respectively, 
may also trigger melanoma by promotion 
of cell differentiation. It appears, however, 
that in this case neither of these agents acts 
as a mutagen, but as a differentiation-pro-
moting agent such as testosterone, TP~ 
and cyclamate, which are certainly not 
mutagens. 
The assumption that any somatic mu-
tation. including that of a possible back 
mutation or suppressor mutation for the g 
mutation, is not involved in the promoting 
effect is compatible with the multicellular 
origin of the melanoma and with the high 
frequency of the respondents, which, in the 
case of 17 -methyltestosterone, even reaches 
100%. Optimization of the treatment in fu-
ture experiments will show whether the 
promoting effect of a certain agent is an all-
or-nothing eff~ as is conceivable on the 
basis of the concept of this experiment. 
Since somatic mutations are probably 
not involved in the trigger for melanoma 
development in this experimen~ one could 
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speculate that the. g m utatio~ undergoes a 
general modificatton that bnngs the func-
tion of g close to the normal function of the 
original g+. The pro~oting eff~ct '?f 
5-azacytidine could be tnterpreted tn thts 
direction. This agent creates undermethy-
lation in the DNA and, as a consequence, 
presumably gene activati~n_[9, 40,.41]. As 
shown in Fig. 17, 5-azacytldtne, whtch pro-
motes differentiation, also demethylates 
DNA of Xiphophorus. More data are re-
quired to correlate the removal of t.he tu-
mor-protecting effect of the g-ml!tatton by 
5-azacytidine with DNA methylatton. . . 
The crucial event leading to neoplas1a tn 
this experiment is the promotion of cell dif-
ferentiation and possibly a more gener~l 
modification of a gene that is involv~d tn 
cell differentiation. The oncogene ttself 
probably remained unchanged. 
VII. Seventh Experiment: Tumors 
Induced by Elimination of a Differen-
tiation Gene from the Germ Line and 
Impairment ofThat Gene in Somatic Cells 
To study the effect of the differentiation 
gene (Difj}, thousands of melanoma-bear-
ing BC segregants were produced accor~­
ing to the crossing procedure shown tn 
Fig. 5, and all showed a clea~-cut 1: 1 
segregation into animals developtng. spon-
taneously benign (Fig. SE) or malignant 
melanomas (Fig. 5 F). BC hybrids that re-
quire the carcinogenic trigger for the devel-
opment of melanoma also show a clear-cut 
Diffetrect (Fig. 11, see third experiment). 
Morphological, histological, cytologtcal, 
fine structural, biochemical, and molecular 
studies showed that the majority ofthe cells 
of the benign melanoma areweil differen-
tiated whereas those ofthe malignant mela-
noma are poorly differentiated, and th~t 
ditferentiation of the transformed cells ts 
controlled by Diff [42, 43]. The most con-
vincing data supporting D{ff-dep~nde~t 
control of pigment-cell differentia~on 10 
melanoma come from transplantat1on ex-
periments which have shown that pigment-
cell precursors present in the transplants 
tak:en from fisb carrying the deregulated Tu 
and lacking Diff (material of still tumor-
free early embryos of the malignant-mela-
mnm5s2u 
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V 
~ mcm5s2u rn6A mo5u m1G cmo5u m11 
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cmcm5u 
noma-developing genotype according to 
the fish shown in Fig. 5 F) become trans-
~orme~ and remain incompletely differen-
bated tf transplanted into embryos laclcing 
Tu ~nd Di.ff: The resulting animals develop 
malignant melanoma. If, however, the pig-
ment-cell precursors of the same genotype 
are transplanted into Tu-lacking embryos 
that contain the Diff gene, the cells of the 
d~veloping melanoma become tenninally 
dtff~rentiated and regain their distance reg-
ulation: These resulting animals develop 
extreme benign melanomas which regress 
and eventually may become removed by 
macrophages (see [ 1]). 
Further studies on the Diff etfect on 
melanoma in Xiphophorus were stimulated 
by the experimental results of other 
laboratories that have focused on the in-
Fig. 18. General cloverleaf 
structure of the tRNA and 
positions of modified 
nucleosides. Bot1om left, 
structure of q ueuosine ( Q). 
Modified from (49] 
volvement of nucleotide modifications of a 
certain tRNA fa~ily in cell differentiation 
in eubacteria, slime molds, and cell cultures 
from different vertebrates [43-48). These 
tRNAs include tRNAAsn, tRNAAsP, 
tRNA His, and tRNA Tyr, which usually con-
tain queuosine (Q) instead of guanosine 
(G) in the first position of the antico-
don (position 34; see arrow in Fig. 18). 
The Q nucleoside (7-(((4,5-cis-dihydroxy-
2-cyclopenten-1-yl) -amino) -methyl-7-de-
azaguanosine) is unique in that its purine 
skeleton is modified to a 7 -deazastructure. 
Eubacteria synthesize the base queuine de 
novo whereas vertebrates are supplied with 
queuine by nutrition or the intestinal flora. 
Queuine itself is inserted into the nucleo-
tide chain of tRNA by an exchange with 
guanine. This process is catalyzed by 
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Fig. 19A-C. lncorporation of ['H]guanine in 
position 34 oftRNA for Asp, Asn, His. and Tyr of 
Xiphophorus catalyzed by tRNA-guanine-trans-
glycosylase (insertase) of E. co/i. The graphs 
show the kinetics of the exchange of 034 of 
tRNA by p H] guanine, a reaction used to evalu-
ate the amount of (Q-)tRNA [50]. A-C accord-
ing to the fish shown below the curves. These fish 
correspond to those shown in Fig. 5. High in-
corporation of [3 H]guanine in DW-lacking ani-
mals corresponds to a low content of Q, whereas 
low incorporation of [3 H) guanine in Diff-con-
taining animals corresponds to a high content of 
Q. A Skin of purebred Xiphophorus: 0, X. hel-
leri; e , X. macu/atus. B Melanoma of BC seg-
regants: 0 , malignant; • ~ benign. C Skin of 
nonmelanomatous BC segregants: ~ , lacking 
Diff; A. containing Diff. Note that comparable 
DW:containing animals always have a lower G 
content and a higher Q content than DW-lacking 
ones. Data from [43, 44, 511 
tRNA-guanine-transglycosylases. The more 
the cells are differentiated, the more re-
placement of G by Q is observed in posi-
tion 34. 
The method for estimating the G : Q ratio 
in a given population of the tRNA family 
consisted of following the replacement of 
guanine in position 34 by a 1H-labeled 
gua~ne exerted by a guanine-transglycosy-
lase (ansertase) of Escherichia coli [50, 51}. 
The results obtained in Xiphophorus by 
measurement of [lH] guanine incorporation 
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into the tRNAs ofthe Q family, differing in 
the ratio of G: Q in position 34, are sum-
marized in Fig. 19. TI:te· gniphs show the 
kinetics of the exchange of G 34 of the 
tRNA family by (3 H]guanine, which is the 
reaction used to evaluate the amount of 
(Q-)-tRNA. The fish genotypes and pheno-
types are identical to those shown in Fig. 5. 
In accordance with the findings of many 
investigators working with other differen-
tiation systems [52], [lH] guanine inc?rpor-
ation is high in tRNAs from mabgnant 
melanomas that consist predominantly of 
poorly differentiated cells; In contrast, the 
incorporation is lower if the tRNAs are d.e-
rived from benign melanomas tha t cons1st 
predominantly of well-differentiated cells. 
Therefore, tRNAs of malignant melanomas . 
have a higher amount of G in place of Q 
than those of the benign melanomas 
(Fig. 19 B). · 
To decide whether the distinct difference 
in G: Q ratios between benign and malig-
nant melanoma is Diff dependen t or rep-
resents an epiphenomenon of benignancy 
and malignancy, the skin of nontum?rous 
littermates that segregate into anunals 
carrying Diff and lacking Diff like the tu-
morous fish in a I : 1 ra tio was used for 
analysis (Fig. 19 C). The DW-lacking 
segregants always bad higher amounts ~f 
Q-lacking tRNA than the Diff-carrying aru-
mals. The skin of the parent animals used 
A 
B 
für the initial crosses showed thc same dif-
ferences ( Fig. 19-A): X." helleri, which Iacks 
the Dijj' gene, has_a· high PI-I]guaninc in-
corporation (i.e., is G.;.rich) whereas X. 
maculatus, which contains the Dij]' genc~ 
has a lower [lH] guanine incorporation. 
~rom these results we suggest that the dif-
ference of G: Q ratios between benign and 
malignant melanoma are not epipheno-
nlena of benignancy and malignancy, but 
are closely related to the primary eflect of 
the Diff gene. 
The differences in the functional proper-
ties of Q-eontaining and Q-lacking tRNAs 
require further elucidation. The (Q)tRNAs 
have bee'n suggested to prefer codons NAU 
to NAC~ whereas the Q-lacking tRNAs 
read NAC and NAU equally well [46]. This 
may b~ an important mechanism in the 
regulation of translation. For eukaryotic 
tRNATyr it has been shown that the Q-lack-
ing species reads a terminator codon, prob-
ably ·UAG. Therefore the Q-lacking and 
Q-<;ontaining tRNAs of vertebrates might 
select mRNAs tbr translation by a regu-
latory mechanism similar to that of termi-
~ation transcription control (see discussions 
tn ref. [51]). 
I f benignancy depends on the presence 
of a single copy of .Diff and malignancy on 
t~e Iack oftbis copy then it should be pos-
sible to induce easily somatic mutation-
.. 
Fig. 20A,B. Development 
ofinduced somatic mu-
tation-conditioned malig-
nant melanomas on a cros.-,-
ing-conditioned supcrficial 
hereditary melanoma. A 
Untreated fish; B Fish 
treated with X-ravs. It is as-
sumed that the in .. duced 
melanomas are due to an 
impairment ofthe diffcrcn-
tiation gene Dif!in a pig-
ment-cell pnx~ursor cach 
conditioned n1alignant melanoma in the 
area of germinal-conditioned benign mela-
.noma. For this purpose we treated super-
ficial benign me1anoma with f\.1NU or 
X-rays and observed the development of 
focal malignant melanoma in the area of 
the benign mela noma ( Fig. 20). This is not 
to say that the benign melanoma changes 
to the malignant state. In contrast, the so-
nlatic mutation-conditioned malignant 
tnelanoma develops independently from 
the already present germ-line-conditioned 
benign melanoma. The induced malignant 
melanoma, however, competes with the 
hereditary benign melanoma for pigment-
cell precursors. As a conseq uence of lhis 
competition the focal malignant mela-
nomas are surrounded by a halo-like zone 
that is sparsely polulated by the cells of the 
benign melanoma. 
This experiment shows once more tbat 
the genesthat carcinogens act upon if they 
trigger neoplasia are not necessarily the on-
cogenes themselves, but their regulatory 
genes in the broadest sense. 
D. Conclusions 
In our XiphophonJs model we have not 
found any genetic change of the Mendelian 
inherited oncogene Tu that might Iead to 
neoplasia~ although one would expect this 
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Fig. 21. Distribution of the c-src onco-
gene in living organisms. All organ-
isms listed have been tested. c-src was 
found in all multicellular animals 
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tobe possible based on the molecular find-
ings of other laboratories that mutation, re-
arrangement. amplification. and demethy-
lation can convert a silent oncogene to the 
transforming state. In contrast, our carcino-
genesis studies show that the most impor-
tant process invoJved in neoplasia in tbese 
animals is loss, impairment, or any other 
dysfunction of the reguJatory gene system 
of the Tu oncogene. About 20 regulatory 
genes controlling the oncogene Tu at the 
gene Ievel have been identified genetically 
and phenotypically. These genes comprise 
tissue-specific and compartment-specific 
(eye, mouth. etc.) regulatory genes (first to 
fifth experiments). Once the system oftbese 
regulatory genes controlling Tu is im-
paired, a chain of events is begun that can 
Iead straight to neoplasia, but can also be 
interrupted by a genetic block of cell differ-
entiation which protects tbe animal from 
the transforming activity of the oncogene. 
This protection mechanism can, however, 
easily be broken by promotion of cell dif-
ferentiation (sixth experiment). If, finally, 
the cells are transformed, tumor growth can 
be stopped by terminal differentiation of 
the tumor cells exerted by the differen-
tiation gene. Loss or impairment of the dif-
ferentiation gene. then, Ieads definitely to 
neoplasia (seventb experiment). Our car-
cinogenesis experiments indicate that it is 
tbe regulatory genes (in the broadest sense) 
and not the oncogene itself that the car-
cinogens commonly act on, when they trig-
ger neoplasia in X iphophorus. 
The inheritance and phenotypic expres-
sion of the genetically defined Tu oncogene 
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parallels completely the expression of the 
molecularly defined c-src oncogene. Re-
gardless of any future findings that might 
bring Tu substantially in relation to c-src 
and/ or any other c-onc, botb Tu ~nd c-s~c 
act, are regulated, and are inhented as 1f 
they were the same chromosomal gene of 
the natural gene pool of the Xipho_phorus 
fish. 
c-src has been found functioning in all 
taxonomic groups of multicellular animals 
ranging from mammals down to the spong-
es (Fig. 21) [16, 53], and intensive efforts 
are being made in many laboratories to de-
termine whether a cellular oncogene, such 
as c-src, is capable of mediating neoplastic 
transformation like its viral counterpart [3, 
54-59]. If this should be proven we suggest 
that all individuals of all metazoa are en-
dowed with tbe capacity to develop neo-
plasia. Support for tbis idea comes from the 
fact that neoplasia is distributed- although 
sporadically - in all groups of m ulticellular 
animals [60-62]. Ubiquity of the oncogene 
in metazoa including bumans on the one 
band and theinfrequent occurrence ofneo-
plasia in all these organisms on the o_ther 
band raises the question of the mechaniSms 
that protect the majority of the individua!s 
of all metazoans from tbe action of tbeu 
own oncogenes. The Xiphophorus model 
provides an opportunity to contribute to 
the study oftbis problem. 
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